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〈〉研究目的
中枢神経系疾患の病態と発症機構に関する薬理学的研究を行うとともに、和漢薬をはじめ、複
合成分からなる薬物の薬効に関する計量薬理学的評価、作用本体の追求および分子レベルでの作
用機序の解明を目的とした研究を行っている。
〈〉研究概要
I) 中枢神経系疾患の病態と発症機構に関する基礎研究
1) 心理的ストレス反応に関わる神経機構、神経機能修飾因子とその作用分子機構の解析
2) 病態モデルにおける神経伝達物質、－酸化窒素の脳内動態とそれに苅する薬物作用の解析
II) 複合薬物及びその成分の中枢作用に関する神経薬理学的研究
1) 脳血管性痴呆病態モデル系における和漢薬および和漢薬成分の抗痴呆作用と神経保護作用
の評価
2) 新規リード化合物の開発をめざした伝統薬物・民族薬の薬理作用の探索と作用機序の解析
3) 受容体遺伝子発現系を用いた薬物作用と作用機序に関する電気生理学的解析
m) 遺伝子発現を指標とした薬物作用の解明と和漢薬作用に関する研究
1) 慢性脳虚血により発現する脳内遺伝子のク口一二ングとその機能解析
2) うつ病態関連脳内遺伝子の発現変化と抗うつ薬・和漢薬の作用解析
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〈〉原著論文
1) Hussein G, Nakamura M., Zhao Q., Iguchi T., Goto H., Sankawa U., and Watanabe H.: 
Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol. 
Pharm. Bull., 28: 47-52, 2005. 
Abstract: Astaxanthin is a natural antioxidant carotenoid that occurs in a wide variety of living 
organisms. We investigated, for the first time, antihypertensive effects of astaxanthin (ASX-0) in 
spontaneously hypertensive rats (SHR). Oral administration of ASX-0 for 14 d induced a significant 
reduction in the arterial blood pressure (BP) in SHR but not in normotensive Wistar Kyoto (WKY) strain. 
The long-term administration of ASX-0 (50 mg/kg) for 5 weeks in stroke prone SHR (SHR-SP) induced 
a significant reduction in the BP. It also delayed the incidence of stroke in the SHR-SP. To investigate the 
action mechanism of ASX”0, the effects on PGF(2alpha）ーinducedcontractions of rat aorta treated with 
N(G)-nitro-1-arginine methyl ester (L-NAME) were studied in vitro. ASX-0 (1 to 10 μM) induced 
vasorelaxation mediated by nitric oxide (NO). The results suggest that the antihypertensive effect of 
ASX-0 may be due to a NO-related mechanism. ASX-0 also showed significant neuroprotective effects 
in ischemic mice, presumably due to its antioxidant potential. Pretreatment of the mice with ASX-0 
significantly shortened the latency of escaping onto the platform in the Morris water maze learning 
performance test. In conclusion, these results indicate that astaxanthin can exert beneficial effects in 
protection against hypertension and stroke and in・improving memory in vascular dementia. 
2) Mahakunakorn P., Tohda M., Murakami Y., Watanabe H., and Matsumoto K.: Effects of 
Choto・sanand Its Related Constituents on Endogenous Antioxidant Systems. Biol. Pharm. 
Bull., 28: 53・57,2005. 
Abstract: We previously reported that Choto-san acts as an antioxidant and cytoprotective agents 
against H202-induced oxidative damage in NG 108-15 cels, and the effect is due at least partly ta the 
phenolic compounds. To further investigate the detail mechanisms of this cytoprotection, effects of 
Choto-san and related compounds on enzyme activities of antioxidant systems were examined. 
Choto-san (5-100 μg/ml) and Chotoko (5-100 μg/ml) stimulated the activity of superoxide dismutase 
(SOD), catalase and glutathione peroxidase (GPX). These also increased the level of glutathione. 
Although Choto-san without Chotoko (w/o CKO) did not show the effects on SOD and catalase, GPX 
activity and glutathion content also, but weakly, stimulated by w/o CKO. The effects of phenolic 
compounds, epicatechin, ca汀eicacid and quercetin were also investigated. Epicatechin stimulated 
catalase, GPX and glutathion content, but not SOD. On the other hand, caffeic acid stimulated SOD 
activity but had no effects on others. Quercetin stimulated al, although intensities were different 
among. These results suggest that simultaneous induction of cellular antioxidant defense systems by 
Choto-sam and its related constituents may be an important mechanisms underlying the protective 
effects of Choto-san on ischemia-induced neuronal cells injury, and the characteristics of the 
stimulative effects of phenolic compounds were depend on enzymes. 
3) Hayashi H., Tohda M., Watanabe H., Murakami Y., and Matsumoto K.: The Effects of 
Cho to・sanon the mRNA Expression of Alzheimer’s Disease Related Factors in the 
Permanent lschemic Rat Brain. Biol Pharm. Bull., 28: 744-746, 2005. 
Abstract: Choto-san is a Kampo medicine that has been used clinically for the treatment of dementia. We 
measured the mRNA expressions of some factors related to Alzheimer’s disease in a dementia model rat 
brain. The expressions of beta-amyloid precursor protein, gamma-secretase, alpha? nicotinic 
acetylcholine receptor, neprilysin, and insulin degrading enzyme (IDE) were significantly increased on 
day 4 after permanent occlusion of the bilateral common carotid arteries (2VO). Choto-san inhibited the 
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enhancement of IDE expression caused by 2VO, although it failed to show any effects on the expressions 
of the other molecules. These results suggest that Choto-san may produce a state in which it is not 
necessaηto induce IDE expression to demonstrate the anti-dementia effects. 
4) Hussein G, Goto H., Oda S., Iguchi T., Sankawa U叫 MatsumotoK叫 andWatanabe H.: 
Antihypertensive Potential and Mechanism of Action of Astaxanthin: I. Vascular Reactivity 
and Hemorheology in Spontaneously Hypertensive Rats. Biol. Pharm. Bull., 28: 967-971, 
2005. 
Abstract: The current study was designed to determine the effects of a dietary astaxanthin (ASX-0) on 
vascular reactivity in spontaneously hypertensive rats (SHR), in order to verify its antihypertensive action 
mechanism. We evaluated contractions induced by phenylephrine (Phe ),angiotensin I (Ang I) and the 
xanthine/xanthine oxidase (Xan/XOD) systemラandrelaxations induced by sodium nitroprusside (SNP) as 
well as endothelium-dependent relaxations mediated by acetylcholine (ACh) in thoracic aorta of the SHR, 
with and without ASX-0 intervention. We also investigated the effects of ASX-0 on blood rheology 
using a microchannel array system. In this studyラASX-0showed a significant modulatory effect on nitric 
oxide (NO）ーinducedvasorelaxation by the NO-donor SNP (p<0.05). However, it did not show significant 
effects in restoring the impaired endothelium-dependent relaxation to A Ch in the SHR. On the other hand, 
the constrictive effects by Phe, Ang I and Xan/XOD were ameliorated by ASX-0 (p<0.05). ASX-0 also 
demonstrated significant hemorheological effect by decreasing the microchannel transit time of whole 
blood. In conclusion, the results suggest that ASX-0 may act in modulating the blood fluidity in 
hypertension, and that the antihypertensive effects of ASX-0 may be exerted through mechanisms 
including normalization of the sensitivity of the adrenoceptor sympathetic pathway, particularly 
[alpha ]-adrenoceptorsラandby restoration of the vascular tone through attenuation of the Ang I-and 
reactive oxygen species (ROS）ーinducedvasoconstriction. 
5) Murakami Y., Zhao Q., Harada K., Tohda M., Watanabe H., and Matsumoto K.: Choto皿san,
a Kampo formula, improves chronic cerebral hypoperfusion圃inducedspatial learning deficit 
via stimulation of muscarinic M1 receptor. Pharmacol, Biochem. Behatζ，81:616・625,2005. 
Abstract: A recent double-blind and placebo-controlled study demonstrated a beneficial effect of 
Choto-san, a Kampo (traditional medicine of Japan) formulaラoncognitive impairment in patients with 
vascular dementia. Howeverラtheneuronal mechanism underlying the therapeutic effects of this formula 
remains to be clarified. Using a chronic cerebral hypoperfusion model, we investigated the effect of 
Choto-san on cognitive dysfunction in mice to clarify its mechanism of actions. Chronic cerebral 
hypoperfusion was induced by permanent occlusion of both the common carotid arteries (2VO). 
Choto-san and Uncaria, a major constituent of Choto-san, caused an improvement in 2VO-induced 
learning deficitsラwhereasUncaria-free Choto-san did not. The effects of Choto-san and Uncαria were 
blocked by pirenzepine, a selective muscarinic M1 antagonist. In a tube-dominance test, 2VO induced an 
increased rates of assertive behavior in mice. 2VO mice administered Choto-san showed significantly 
reduced rates of assertive behavior compared to vehicle-treated controls, whereas Uncaria-free Choto-san 
and Uncαria had litle effect on 2VO-induced assertive behavior. 2VO caused a significant decrease in the 
level of acetylcholine (A Ch) contents in the brainラandthe daily administration of Choto-san or Uncaria 
raised the ACh level to that in the sham-operated controls. These results suggest that Choto-san has an 
ameliorating effect on the spatial memory deficit caused by chronic hypoperfusion, and that the effect is 
mainly attributable to Uncaria. Moreover, it was suggested that the effects of Choto-san and Uncaria are 
at least partly mediated by stimulation of the muscarinic M 1 receptor. 
6) Nguyen T.T.H., Murakami Y., Tohda M., Watanabe H., and Matsumoto K.: Social isolation 
stress-induced oxidative damage in mouse brain and its modulation by majonoside-R2, a 
Vietnamese ginseng saponin. Biol. Pharm. Bull., 28: 1389・1393,2005. 
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Abstract: Stressors with a physical factor such as immobilization, electric foot shock, cold swim, etc., 
have been shown to produce oxidative damage to membrane lipids in the brain. In this study, we 
investigated the effect of protracted social isolation stress on lipid peroxidation activity in the mouse brain 
and elucidated the protective effect of m司onoside-R2,a major saponin component of Vietnamese 
ginseng, in mice exposed to social isolation stress. Thiobarbituric acid reactive substance (TEARS), one 
of the end products oflipid peroxidation reaction, levels were increased in the brains of mice subjected to 
6-8 weeks of mice to social isolation stress. Measurements of NO metabolites (NOx-) also revealed a 
significant increase of NO production in the brains of socially isolated mice. Moreover, the depletion of 
brain glutathione content, an endogenous antioxidantラinsocially isolated animals occurred in association 
with the rise in lipid peroxidation. The intraperitoneal administration of majonoside-R2 (10-50 mg/kg) 
had no effect on TEARS, NOラorglutathione levels in the brains of group-housed control mice but it 
significantly suppressed the increase in TEARS and NO levels and the decrease in glutathione levels 
caused by social isolation stress. These results suggest that subjecting mice to 6-8 weeks of social 
isolation stress produces oxidative damage in the brain partly via enhancement of NO productionラandthat 
majonoside-R2 exerts a protective effect by modulating NO and glutathione systems in the brain. 
7) Matsumoto K., Morishige R., Murakami Y., Tohda M., Takayama H., Sakakibara I., and 
Watanabe H.: Suppressive effects of isorhynchophylline on 5・HT2a receptor function in the 
brain: behavioural and electrophysiological elucidation. Eur. J. Pharmacol., 517: 191・199,
2005. 
Abstract: Isorhynchophylline (IRHY) is a m司oroxindole alkaloid found in Uncaria species which have 
long been used in traditional Chinese medicine. Hereラ weinvestigated the effects of IRHY and 
IRHY二relatedalkaloids on 5-HT receptor-mediated behavioural responses in mice and 5-HT-evoked 
current responses in Xenopus oocytes expressing 5-HT2A or 5-HT2c receptors. IRHY dose-dependently 
inhibited 5-HT 2A receptor-mediated head-twitch but not 5-HT IA receptor-mediated head-weaving 
responses evoked by 与methoxy-NラN-dimethyltryptamine.Pretreatment with reserpine, a monoamine-
depleting agent, enhanced the head-twitching, but did not influence the effect of IRHY on the behavioural 
response. Isocorynoxeine (ICOX), an IRHY司relatedalkaloid in which the configuration of the oxindole 
moiety is the same as in IRHY, also reduced the head-twitch response in reserpinized mice over the same 
dose range as IRHY, while both rhynchophylline and corynoxeine, stereoisomers ofIRHYand ICOX, did 
not. None of the alkaloids tested had an effect on meta-chlorophenylpiperazine-induced hypo locomotion, 
a 5-HT2c receptor-mediated behavioural response. In experiments in vitro, IRHY and ICOX 
dose-dependently and competitively inhibited 5-HT-evoked currents in Xenopus oocytes expressing 
5-HT2A receptors, but had less of a suppressive effect on those in oocytes expressing 5-HT2c receptors. 
These results indicate that IRHY and ICOX preferentially suppress 5-HT2A receptor function in the brain 
probably via a competitive antagonism at 5-HT2A receptor sites and that the configuration of the oxindole 
moiety ofIRHY is essential for their antagonistic activity at the 5-HT2A receptor. 
8) Li X.’Matsumoto K., Mm 
effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by 
paraquat and maneb in mice. Pharmacol. Biochem. Beha1勺82:345・352,2005. 
Abstract: The neuroprotective effects of Polygonum multiflorum extract (PME) and its two fractions, 
ethanol-soluble PME (PME-1) and -insoluble PME (PME-11) fractions, on the degeneration of 
nigrostriatal dopaminergic neurons induced by a combination of paraquat and maneb (PQMB) were 
investigated in male C57BL/6 mice. The mice were treated twice a week over 6 weeks with 
intraperitoneal in ections of PQMB. This combination caused a reduction of spontaneous locomotor 
activity, motor incoordination, and declines of dopamine levels in the striatum and tyrosine 
hydroxy lase-positive neurons in the substantia nigra. Administration of PME and PME-1 once daily for a 
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total of 46 days during the 6-week period of PQMB treatment and an 8-day period following the 
termination of PQMB treatment significantly attenuated the impairment of behavioral performance and 
the decrease in striatal dopamine levels and substantia nigral tyrosine hydroxylase-positive neurons in the 
PQMB-treated animals, whereas the administration of PME-II had no effect on these behavioral, 
neurochemical and histological indices. The present findings suggest that PME has a beneficial influence 
on parkinsonism induced by PQMB and that the effects of PME are attributable to some substance(s) 
included in the ethanol-soluble fraction of P恥1E.
9) Zhao Q., Murakami Y., Tohda M., Watanabe H., and Matsumoto K.: Preventive effect of 
chotosan, a Kampo medicine, on transient ischemia is mediated by stimulation of 
muscarinic M1 but not nicotinic receptor. Biol. Pharm. Bull., 28: 1873・1878,2005. 
Abstract: We have previously shown using a water maze task that transient 2 vessel occlusion (T2VO) 
induced learning deficit in mice and that the deficit was prevented by pre-treatment of mice with 
chotosan, a Kampo prescription. In this study, we investigated the mechanism underlying the preventive 
effect of chotosan on T2VO-induced learning deficit. Chotosan administration 1 hour before T2VO 
operation prevented leaning impairment. The extract of Uncaria, a major constituent of chotosan, also 
had a protective effect on learning impairment in T2VO mice, whereas Uncaria-free chotosan did not had 
no beneficial effect on maze performance of T2VO mice. The ameliorative effect of chotosan was 
blocked by pirenzepine, a muscarinic M 1 antagonist, but not by mecamylamine, a nicotinic receptor 
antagonist. Acetylcholine (A Ch) content in the hippocampus of T2VO mice was significantly lower than 
that in the hippocampus of sham-operated control mice. Chotosan and Uncaria administration attenuated 
T2VO-induced reduction of ACh levels in the brain. These results suggest that the preventive effect of 
chotosan on transient ischemia-induced learning impairment is mainly attributable to the effect of 
Uncaria and that the ameliorative effect is mediated by stimulation of muscarinic M1 receptor. 
10) Sukma M., Tohda M., Watanabe H., and Matsumoto K.: The mRNA expression differences 
of RNA editing enzymes in differentiated and undifferentiated NG108-15 cells. J. Pharmcol. 
Sci., 98: 467-470, 2005. 
Abstract: We previously reported that NG 108-15 cells contain intrinsic serotonin 2C receptor 
(5-HT2CR). The effects of imipramine, a 5-HT2CR antagonist, on cell growth, cell viability, and the 
5-HT2CR mRNA level were investigated in this study. Repeated treatment with imipramine at 
concentrations of 1 -10 μM for 5 days inhibited cell growth in a concentration-dependent manner without 
affecting cel viability. In addition, the level of 5-HT2CR mRNA was elevated. At 30 μM, imipramine 
significantly reduced cell viability. Our findings suggest that the effect of imipramine on neuronal growth 
may be related to its effects on 5-HT2CR. 
11) Nguyen時'I.T. T., Aware S., Tezuka YらShiL., Zadi F.H., Ueda J., Tran Q.L., Murakami Y., 
Matsumoto K., and Kadota S.: Hypouricemic effect of acacetin and 4,5・0・dicaffeoylquinic
acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Biol. 
Pharm. Bull., 28: 2231・2234,2005. 
〈〉総説
1) Matsumoto K., Pinna G, Puia G, Guidotti A., and Costa E.: Social isolation stress-induced 
aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress, 8(2): 
85・93,2005. 
2) 松本政三， A.Guidotti, E. Costa：ストレスと睡眠・情動障害：神経ステロイド・
allopregnanolone系の関与ラ日本薬理学雑誌， 126(2):107-112, 2005. 
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〈〉学会報告 （＊：特別講演、シンポジウム、ワークショップ等）
1) Sumanont Y. Mur沈amiY., Tohda M., Vajragupta 0., Watanabe H., Matsumoto K.: Manganese 
complexes of curcumin and diacetylcurcumin suppress NO production in the rat hippocampus: a 
microdialysis study.第 78回日本薬理学会年会，2005,3/22-24，横浜．
2) 林寿枝，東田道久， SaelimN.，村上孝寿ラ松本欣三：アミロイド前駆蛋白および関連因子
mRNA発現制御による初代培養細胞の状態変化．第78回日本薬理学会年会，2005ラ3/22-24,
横浜．
3) Hussein G.ラ GotoH.ヲ Oda S., Iguchi T., Sankawa U., Matsumoto K., Watanabe H: 
Antihypertensive action mechanisms of astaxanthin in SHR.第 78回日本薬理学会年会， 2005,
3/22-24ラ横浜．
4) Hussein G., Goto H., Nakamura M.ラZhaoQ., Iguchi T., Oda S., Sankawa U., Matsumoto K., 
Watanabe H: Antihypertensive and neuroprotective potentials of astaxanthin.日本薬学会第 125
年会，2005,3/29-31，東京．
5) Hussein G., Goto H., Oda S., Iguchi T.ラ SankawaU., Matsumoto K., Watanabe H: 
Antihypertensive and neuroprotective potentials of astaxanthin in experimental animals. The 14th 
International Symposium on Carotenoids, 2005, 7/17-22, Edinburgh, UK. 
6) Hussein G., Goto H., Oda S.ラIguchiT., Sankawa U., Matsumoto K., Watanabe H: Mechanisms of 
the antihypertensive effects of astaxanthin in spontaneously hypertensive rats. The 14th 
International Symposium on Carotenoids, 2005, 7/17-22, Edinburgh, UK. 
7) Li X., Murakami Y., Matsumoto K., Tezuka Y., Wu Y., Kadota S.: Protective effect of Polygonum 
multiflorumon nigrostriatal dopamine neuron damage caused by paraquat and manbe in mice.第
22回和漢医薬学会大会，2005,8/20-21，東京．
8) 越商，村上孝寿，東田道久，榊原巌，松本版三：釘藤鈎の抗高血圧作用及び一過性脳虚
血誘発空間認知障害に対する予防作用：華鈎藤と鈎藤の薬理作用の差異．第22回和漢医
薬学会大会，2005,8/20-21，東京．
9) 村」二孝寿ラ李霞ラ松本政三，手塚康弘，門田重利：パーキンソン病モデル動物の黒質線条体
ドパミン神経系障害に苅する何首烏の保護効果．第56回日本薬理学会北部会，2005ラ10/4,
新潟．
10) Hussein G., Goto H., Oda S., Iguchi T.ラ SankawaU., Matsumoto K., Watanabe H: 
Antihypertensive potential and action mechanisms of astaxanthin in spontaneously hypertensive 
rats.第 l回7スタキサンチン研究会，2005ラ11/8，東京．
11) 村上孝寿，越時ラ東田道久ラj度濯裕司，松本欣三：脳虚血誘発のマウスの空間認知障害に苅
する釣藤敵の効果．第 16回天然薬物の開発と応用シンポジウムラ 2005ラ11/10-11，東京．
12) Tohda M吋 MatsumotoK.: Up-regulation of amyloid precursor protein mRNA expression and its 
putative role in neuron. The 3rd Takeda science foundation symposium on pharmasciences, 2005, 
12/5-7，東京．
く〉招待講演
1) 松本欣三：釣藤叡ーその抗痴呆効果の薬理学的裏付けー．平成16年度北陸調剤情報セミナ
ラー2005,2127，金沢．
2) Tohda M.: Identification of the Intrinsic Factors Involving the Generation and/or Regulation of 
Psychological Disorders by Wakan-yaku, 2005/7/14-15, Toyama. 
3) 松本政三：漢方薬成分によるストレスの緩和．ストレス社会が求める癒し系食昂の開発．
日本食毘機械研究会，2005,7/20？，東京．
4) 総本版三：脳血管性痴呆モデル系における釣藤敵の薬理作用．日本東洋医学会北陸支部石
56 
川部会「湯本求員記念学術講演会J'2005, 9124，金沢．
5) 松本政三：脳血管性認知症病態モデル系における釣藤叡の薬理作用とその機序．大学勤務
医のための漢方医学セミナー，2005,11/19，岡山．
6) 松本版三：脳血管性認知症と和漢薬：病態モデ、ル系における釣藤敵の作用を中心として．
富山漢方会，2005,11/25，富山．
〈〉共同研究
学内
1) 門田重利：富山大学和漢医薬学総合研究所，「何首烏のドパミン神経損傷に苅する保護
作用J' 2004, 5～ 
2) 後藤博三：富山大学和漢医薬学総合研究所， r Astaxanthin含育ヘマトコッカス藻抱出物
の薬理作用に関する研究J'2001, 4/1～ 
国内
1) 相見則郎、高山虞光、北島満里子：千葉大学大学院薬学研究院， fタイ薬用植物中のイ
ンドールアルカロイド類に関する劃薬基礎科学研究J'1994, 4-
2) 三川 潮：富山県伝統医薬センター， rAstaxanthin含有ヘマトコッカス藻抽出物の薬理
作用に関する研究J'2001, 4/1～ 
海外 J
1) グ工ン・チ一・ス一・フ才ン：ベトナム薬物研究所，「ベトナム人参の薬理作用の研究J,
1994, 4 -
2) Erminio CostaラAlessandroGuidotti：米国イリノイ州立大学シカゴ校精神医学研究所ラ「ス
トレス病態における神経活性ステロイドの役割J' 1997ラ4-
3) Opa Vajragupta：タイ王国マヒドン大学薬学部，「SODmimicsの脳血管性障害に苅する抑
制作用の研究J'2001, 4/1 -
4) Li Song：湾陽薬科大学，「ストレス誘発の情動障害及び学習記憶障害に関する神経薬理学
的研究J'2005, 2/16-
〈〉研究費取得状況
1) 文部科学省科学研究費、萌芽的研究（代表：松本欣三）「攻撃行動制御因子の単離同定
と神経生理機能に関する研究J210万(1/2年目）
2) 文部科学省科学研究費、基盤研究B（代表：松本欣三）「漢方薬の薬効を利用した脳血管
性痴呆治療標的分子の探索・同定とその生理機能解析J850万（1/3年目）
3) 文部科学省科学研究費、基盤研究B（代表：東田道久）「和漢薬をプロープとした生体内
機能分子の同定と生理機能・病態変化の解析J1040万(1/3年目）
4) 文部科学省科学研究費、 21世紀中核的研究拠点形成プログラム（分担：松本政三）「東
洋の知に立脚した個の医療の創生J200万
5) 富山県、和漢薬・バイオテクノロジ一研究費、（代表：松本政三）「神経精神性障害に苅
する薬理学的及び分子生物学的解析と応用に関する基礎研究J70万
〈〉研究室在籍者
薬学部3年生：小野和哉
薬学部4年生：前田幸三、水野いず美
大学院後期 3年： Yaowar吋 Sumanont
外国人客員研究員： Ms. Pham Thi Nguyet Hang （ベトナム国立薬用資源研究所， 2005, 10/5-) 
日本学術振興会・拠点大学変流事業
Ms. Pham Thi Nguyet Hang （ベトナム薬物研究所，2005ラ1/15-3/30)
Ms. Chantana Boonyarat （マヒドン大学大学院ラ2005ラ2/5-3/31)
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Ms. Jitima Srisomboon （チユラロンコン大学大学院，2005,2/5-3/31) 
Dr. Boonyong Tantisira （チユラ口ンコン大学薬学部長，2005,3/11-20) 
Dr. Mayuree Tantisira （チユラロンコン大学薬学部，2005,3/11-20) 
Ms. Nguyen Thuy Trang （ベトナム国立薬用資源研究所，2005,10/6-11/4) 
富山伝統医学センター
Dr. Ghazi Hussein (Assistant of Khartoum University, 2001, 4/1-) 
本学学術支流事業
Mr. Li Song （濯陽薬科大学、 2004,11/16 2005, 2/15) 
。学位（修士、博士）取得者
修士（薬学）：
井口知美：Astaxanthin含有ヘマトコッカス藻抽出物の高血圧及び脳虚血性学習障害に苅
する効果
平尾顕三：一過性脳虚血誘発の空間学習認知障害に対する釘藤叡の保護効果とその機序
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